What is propylthiouracil (PTU) used for?

What is Propylthiouracil (PTU) Used For?

Propylthiouracil is an antithyroid medication used to treat hyperthyroidism, primarily in specific clinical situations: first-trimester pregnancy, patients intolerant to methimazole, thyroid storm, and as preparation for definitive therapy when methimazole cannot be used. 1

Primary Indications

PTU inhibits thyroid hormone synthesis and blocks peripheral conversion of T4 to T3, making it effective for controlling hyperthyroidism 1. However, due to serious safety concerns—particularly severe hepatotoxicity that can lead to liver failure and death—its use is now restricted to specific scenarios 1.

Specific Clinical Uses:

In Pregnancy:

• PTU is the preferred antithyroid drug during the first trimester only because methimazole is associated with specific congenital abnormalities (aplasia cutis, choanal and esophageal atresia) during organogenesis 2, 3
• After completing the first trimester, switch from PTU to methimazole to minimize the risk of severe liver toxicity 2
• The conversion ratio is approximately 100-150 mg PTU = 10 mg methimazole 2, 3
• Monitor liver function every 3-4 weeks while on PTU during pregnancy 2

In Non-Pregnant Patients:

• Patients with Graves' disease or toxic multinodular goiter who are intolerant to methimazole 1
• Thyroid storm, where PTU's ability to block peripheral T4 to T3 conversion provides additional benefit 3
• Preparation for thyroidectomy or radioactive iodine when methimazole cannot be used 1
• Patients with minor reactions to methimazole who refuse radioactive iodine or surgery 3

Critical Safety Considerations

Hepatotoxicity is the major concern with PTU:

• Can cause fulminant hepatic necrosis requiring liver transplantation or resulting in death 3, 1
• Risk appears higher in children (estimated 1 in 2,000-4,000) than adults 4
• Liver injury can occur abruptly without warning, and routine monitoring may not prevent severe outcomes 2, 4, 5
• Patients must immediately stop PTU and contact their physician if they develop: jaundice, dark urine, pale stools, right upper abdominal pain, fever, nausea, vomiting, or fatigue 1

Other serious adverse effects include:

• Agranulocytosis (usually within first 3 months) 1
• ANCA-positive vasculitis (risk increases with prolonged use) 3

Dosing Approach

Standard dosing:

• Initial: 50-150 mg three times daily (every 8 hours), depending on hyperthyroidism severity 3
• Maintenance: typically 50 mg two to three times daily 3
• During pregnancy: use the lowest dose needed to maintain free T4 at or slightly above the upper limit of normal while keeping TSH suppressed 3

When PTU Should NOT Be Used

• Methimazole should be the first-line antithyroid drug in virtually all non-pregnant patients 3
• PTU is not recommended in children due to higher hepatotoxicity risk 1, 4
• After the first trimester of pregnancy, switch to methimazole 2, 3
• In breastfeeding mothers, methimazole is preferred over PTU due to hepatotoxicity concerns 3

Clinical Algorithm for PTU Use

1. First trimester pregnancy with hyperthyroidism requiring treatment → Use PTU
2. Second/third trimester or postpartum → Switch to methimazole
3. Non-pregnant adult with hyperthyroidism → Use methimazole unless:
   • Thyroid storm present → Consider PTU
   • Methimazole intolerance/allergy → Use PTU with close monitoring
   • Minor methimazole reaction + refuses surgery/RAI → Consider PTU
4. Children with hyperthyroidism → Avoid PTU; use methimazole or definitive therapy 4

The evidence consistently demonstrates that while PTU remains effective for hyperthyroidism treatment 6, its use should be limited to specific situations where methimazole cannot be used, with particular emphasis on first-trimester pregnancy as the primary appropriate indication 2, 3.